RBC Capital keeps an Outperform rating and $181 price target on Johnson & Johnson after U.S. Bankruptcy Court denied the company’s request ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback